← Leaderboards
Etan Orgel
Children'S Hospital Of Los Angeles
$3,586,468
Attributed
$3,797,506
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $735.1K · FY2016–25$1M$750K$500K$250K$0
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,797,506 · 3
By mechanism
R37$2,359,104 · 1
K23$1,016,326 · 1
R21$422,076 · 1
Top collaborators
- Steven David Mittelman2 shared
Most similar at Children'S Hospital Of Los Angeles
Same institution · by research overlap
- Steven David Mittelman$4,374,347
- Yves Declerck$3,291,482
Others in their field
Top investigators on “Child”
- Barbara Driver · Westat, Inc.$244,454,458
- Sharon A Nachman · Johns Hopkins University$212,395,175
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$195,214,889
- George R Seage · Abt Associates, Inc.$189,009,744
- Carol Nesel · Westat$188,148,170
- Elizabeth A Thom · George Washington University$170,579,744
Research focus
ChildMalignant Childhood NeoplasmChemotherapyMalignant NeoplasmsAdultSamplingPathway InteractionsEnrollmentLaboratoriesInstitutionInsightPhysiologicalToxic EffectLeadEfficacy TestingDesignPhase Iii TrialQuality Of LifePhysiologyRegimenResponsePreventGrowthPrevention
Grant awards (12)
Targeting obesity to improve survival from childhood acute lymphoblastic leukemia$312,066
R37 · FY2025 · CA · contact PI
Adipose Tissue Reprograms Acute Lymphoblastic Leukemia Cells to Facilitate CNS and Bone Invasion$186,003
R21 · FY2025 · CA
Adipose Tissue Reprograms Acute Lymphoblastic Leukemia Cells to Facilitate CNS and Bone Invasion$236,073
R21 · FY2024 · CA
Targeting obesity to improve survival from childhood acute lymphoblastic leukemia$669,866
R37 · FY2023 · CA · contact PI
Targeting obesity to improve survival from childhood acute lymphoblastic leukemia$690,162
R37 · FY2022 · CA · contact PI
Targeting obesity to improve survival from childhood acute lymphoblastic leukemia$687,010
R37 · FY2021 · CA · contact PI
Prevention of Cisplatin-induced Hearing Loss in Children with Cancer$48,074
K23 · FY2021 · DC · contact PI
Prevention of Cisplatin-induced Hearing Loss in Children with Cancer$192,302
K23 · FY2020 · DC · contact PI
Prevention of Cisplatin-induced Hearing Loss in Children with Cancer$193,160
K23 · FY2019 · DC · contact PI
Prevention of Cisplatin-induced Hearing Loss in Children with Cancer$194,011
K23 · FY2018 · DC · contact PI
Prevention of Cisplatin-induced Hearing Loss in Children with Cancer$193,191
K23 · FY2017 · DC · contact PI
Prevention of Cisplatin-induced Hearing Loss in Children with Cancer$195,588
K23 · FY2016 · DC · contact PI